Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Nephrotic Syndrome in Children-Reference-Cited by-同舟云学术

Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Nephrotic Syndrome in Children

Published:2014-03 Issue:3 Volume:63 Page:354-362
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Samuel Susan,Bitzan Martin,Zappitelli Michael,Dart Allison,Mammen Cherry,Pinsk Maury,Cybulsky Andrey V.,Walsh Michael,Knoll Greg,Hladunewich Michelle,Bargman Joanne,Reich Heather,Humar Atul,Muirhead Norman

Publisher

Elsevier BV

Subject

Nephrology

Reference47 articles.

1. KDIGO. KDIGO Mission Statement. www.kdigo.org. Accessed November 20, 2013.

2. Management patterns of childhood-onset nephrotic syndrome;MacHardy;Pediatr Nephrol,2009

3. KDIGO clinical practice guideline for the care of kidney transplant recipients;Am J Transplant,2009

4. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease;Kidney Int Suppl,2012

5. KDIGO practice guidelines for acute kidney injury;Kidney Int Suppl,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Egyptian evidence -based pediatric clinical practice adapted guidelines for management of [1] steroid sensitive nephrotic syndrome (EPG/SSNS 2022);Egyptian Pediatric Association Gazette;2023-02-27

2. Steroid Sensitive Nephrotic Syndrome;Pediatric Kidney Disease;2023

3. Urine Neutrophil Gelatinase-associated Lipocalin as a Prognostic Biomarker in the First Episode of Idiopathic Nephrotic Syndrome in Children;The Journal of Pediatric Research;2022-12-13

4. Current Understanding of Nephrotic Syndrome in Children;Pediatric Clinics of North America;2022-12

5. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations;Therapeutic Drug Monitoring;2022-10